positions available now

Category Archives: MSAC

Relating to the Medical Services Advisory Committee (MSAC)

Defining value in the MBS Review

In May 2015 the Federal Government announced a review of the Medicare Benefits Schedule (MBS) with a view to bringing the MBS up-to-date and increase the value derived from the more than 5,700 listed items. The announcement of this review … Continue reading

Posted in Market Access, MBS, Medicare Benefits Schedule, MSAC, PBAC, PBS | Tagged , , , , , , | Comments Off on Defining value in the MBS Review

Funding pathways for new technologies

Recently, the topic of funding pathways for new technologies was discussed as part of a speaker session at the 2015 ARCS Scientific Congress, at Royal Randwick Sydney. Professor Robyn Ward, the current Chairperson of MSAC and a member of the … Continue reading

Posted in Life Sciences Industry, Market Access, MSAC | Tagged , | Comments Off on Funding pathways for new technologies

Disinvestment in health care: friend or foe?

The clinical trial that led Commercial Eyes Market Access Consultant, Bridie Murphy, into the world of health technology assessment is still in the spotlight five years on. In July, The Conversation featured an article that looked at this and other … Continue reading

Posted in Clinical Development, Commercial Eyes, Life Sciences Industry, Market Access, MSAC | Tagged , , , | Comments Off on Disinvestment in health care: friend or foe?
Copyright © 2014 Commercial Eyes